{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:46:00Z","timestamp":1792788360710,"version":"4.5.0"},"reference-count":36,"publisher":"The Endocrine Society","issue":"5","license":[{"start":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T00:00:00Z","timestamp":1668988800000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Austrian Society for Bone and Mineral Research"},{"name":"MSCA Innovative Training Network FIDELIO"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,13]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Context<\/jats:title><jats:p>MicroRNAs (miRNAs)\u2014short, single-stranded, noncoding RNAs\u2014regulate several biological processes, including bone metabolism.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>We investigated circulating miRNAs as promising biomarkers for treatment monitoring in women with postmenopausal osteoporosis on denosumab (DMAB) therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this prospective, observational, single-center study, 21 postmenopausal women treated with DMAB were included for a longitudinal follow-up of 2 years. Next-generation sequencing (NGS) was performed to screen for serological miRNAs at baseline, month 6, and month 24. Reverse transcription quantitative polymerase chain reaction (RT-qPCR) was used to confirm NGS findings in the entire cohort. Bone turnover markers (BTM) P1NP and CTX, and bone mineral density (BMD) by dual x-ray absorptiometry were assessed and correlated to miRNAs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>BMD at the hip (5.5%, P = 0.0006) and lumbar spine significantly increased (11.4%, P = 0.017), and CTX (64.1%, P &amp;lt; 0.0001) and P1NP (69.3%, P &amp;lt; 0.0001) significantly decreased during treatment. NGS analysis revealed significant changes in miRNAs after 2 years of DMAB treatment but not after 6 months. Seven miRNAs were confirmed by RT-qPCR to be significantly changed during a 2-year course of DMAB treatment compared to baseline. Four of these were mainly transcribed in blood cells, including monocytes. Correlation analysis identified significant correlation between change in miRNA and change in BTMs as well as BMD. Based on effect size and correlation strength, miR-454-3p, miR-26b-5p, and miR-584-5p were defined as top biomarker candidates, with the strongest association to the sustained effect of denosumab on bone in osteoporotic patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Two years of DMAB treatment resulted in upregulation of 7 miRNAs, 4 of which are mainly transcribed in monocytes, indicating a potential impact of DMAB on circulating osteoclast precursor cells. These changes were associated to BMD gain and BTM suppression and could therefore be useful for monitoring DMAB treatment response.<\/jats:p><\/jats:sec>","DOI":"10.1210\/clinem\/dgac667","type":"journal-article","created":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T09:30:14Z","timestamp":1669023014000},"page":"1154-1165","source":"Crossref","is-referenced-by-count":20,"title":["Circulating miRNAs Respond to Denosumab Treatment After 2 Years in Postmenopausal Women With Osteoporosis\u2014the MiDeTe study"],"prefix":"10.1210","volume":"108","author":[{"given":"Zora","family":"Messner","sequence":"first","affiliation":[{"name":"2nd Department of Internal Medicine\u2014VINFORCE, St. Vincent Hospital , 1060 Vienna , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7957-3319","authenticated-orcid":false,"given":"David","family":"Carro V\u00e1zquez","sequence":"additional","affiliation":[{"name":"Department of Biotechnology , University of Natural Resources and Life Sciences Vienna , 1180 Vienna , Austria"},{"name":"TAmiRNA GmbH , 1110 Vienna , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Haschka","sequence":"additional","affiliation":[{"name":"1st Med. Dept. Hanusch Hospital, Ludwig Boltzmann Institute of Osteology at Hanusch Hospital of OEGK and AUVA, Trauma Centre Meidling , 1140 Vienna , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Grillari","sequence":"additional","affiliation":[{"name":"Ludwig Boltzmann Institute for Traumatology, The Research Centre in Cooperation with AUVA , 1200 Vienna , Austria"},{"name":"Austrian Cluster for Tissue Regeneration , 1200 Vienna , Austria"},{"name":"University of Natural Resources and Life Science [BOKU], Institute of Molecular Biotechnology , 1180 Vienna , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinrich","family":"Resch","sequence":"additional","affiliation":[{"name":"2nd Department of Internal Medicine\u2014VINFORCE, St. Vincent Hospital , 1060 Vienna , Austria"},{"name":"Metabolic Bone Diseases Unit, Sigmund Freud University Vienna, School of Medicine , 1020 Vienna , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4105-5361","authenticated-orcid":false,"given":"Christian","family":"Muschitz","sequence":"additional","affiliation":[{"name":"2nd Department of Internal Medicine\u2014VINFORCE, St. Vincent Hospital , 1060 Vienna , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Pietschmann","sequence":"additional","affiliation":[{"name":"Center for Pathophysiology, Infectiology and Immunology, Institute of Pathophysiology and Allergy Research, Medical University of Vienna , 1090 Vienna , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Zwerina","sequence":"additional","affiliation":[{"name":"1st Med. Dept. Hanusch Hospital, Ludwig Boltzmann Institute of Osteology at Hanusch Hospital of OEGK and AUVA, Trauma Centre Meidling , 1140 Vienna , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4136-7293","authenticated-orcid":false,"given":"Matthias","family":"Hackl","sequence":"additional","affiliation":[{"name":"TAmiRNA GmbH , 1110 Vienna , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Kocijan","sequence":"additional","affiliation":[{"name":"1st Med. Dept. Hanusch Hospital, Ludwig Boltzmann Institute of Osteology at Hanusch Hospital of OEGK and AUVA, Trauma Centre Meidling , 1140 Vienna , Austria"},{"name":"Metabolic Bone Diseases Unit, Sigmund Freud University Vienna, School of Medicine , 1020 Vienna , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2022,11,19]]},"reference":[{"issue":"6","key":"2023041309385978400_","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jama.285.6.785","article-title":"Osteoporosis prevention, diagnosis, and therapy","volume":"285","author":"NIH Consensus Development Panel on Osteoporosis Prevention D and Therapy","year":"2001","journal-title":"JAMA"},{"issue":"3):","key":"2023041309385978400_","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00198-021-06152-6","article-title":"Epidemiology and economic burden of fragility fractures in Austria","volume":"33","author":"Muschitz","year":"2022","journal-title":"Osteoporos Int"},{"issue":"1","key":"2023041309385978400_","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00198-018-4704-5","article-title":"European Guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"30","author":"Kanis","year":"2019","journal-title":"Osteoporos Int"},{"key":"2023041309385978400_","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"issue":"8","key":"2023041309385978400_","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"issue":"2","key":"2023041309385978400_","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00198-010-1501-1","article-title":"Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards","volume":"22","author":"Vasikaran","year":"2011","journal-title":"Osteoporos Int"},{"issue":"12","key":"2023041309385978400_","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1002\/jbmr.3565","article-title":"Teriparatide treatment increases mineral content and volume in cortical and trabecular bone of iliac crest: a comparison of infrared imaging with X-ray-based bone assessment techniques","volume":"33","author":"Paschalis","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2023041309385978400_","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1177\/0300985813502820","article-title":"MicroRNAs: history, biogenesis, and their evolving role in animal development and disease","volume":"51","author":"Bhaskaran","year":"2014","journal-title":"Vet Pathol"},{"issue":"5","key":"2023041309385978400_","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"Cell"},{"issue":"7","key":"2023041309385978400_","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1093\/nar\/gkz097","article-title":"An estimate of the total number of true human miRNAs","volume":"47","author":"Alles","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"suppl_1","key":"2023041309385978400_","doi-asserted-by":"crossref","first-page":"R17","DOI":"10.1093\/hmg\/ddl046","article-title":"Non-coding RNA","volume":"15","author":"Mattick","year":"2006","journal-title":"Hum Mol Genet"},{"issue":"D1","key":"2023041309385978400_","doi-asserted-by":"crossref","first-page":"D211","DOI":"10.1093\/nar\/gkab808","article-title":"miRNATissueAtlas2: an update to the human miRNA tissue atlas","volume":"50","author":"Keller","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"2023041309385978400_","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mce.2015.10.015","article-title":"Circulating microRNAs as novel biomarkers for bone diseases\u2014complex signatures for multifactorial diseases?","volume":"432","author":"Hackl","year":"2016","journal-title":"Mol Cell Endocrinol"},{"issue":"18","key":"2023041309385978400_","doi-asserted-by":"crossref","first-page":"6927","DOI":"10.3390\/ijms21186927","article-title":"Circulating MicroRNAs as novel biomarkers for osteoporosis and fragility fracture risk: is there a use in assessment risk?","volume":"21","author":"Ciuffi","year":"2020","journal-title":"IJMS"},{"issue":"11","key":"2023041309385978400_","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.tibs.2012.08.003","article-title":"Extracellular miRNAs: the mystery of their origin and function","volume":"37","author":"Turchinovich","year":"2012","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"2023041309385978400_","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ymeth.2012.09.015","article-title":"Assessing sample and miRNA profile quality in serum and plasma or other biofluids","volume":"59","author":"Blondal","year":"2013","journal-title":"Methods"},{"issue":"6","key":"2023041309385978400_","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jmoldx.2013.07.005","article-title":"Quantification of circulating miRNAs in plasma","volume":"15","author":"Sourvinou","year":"2013","journal-title":"J Mol Diagn"},{"issue":"8","key":"2023041309385978400_","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.3390\/cells9081915","article-title":"Impact of anticoagulation and sample processing on the quantification of human blood-derived microRNA signatures","volume":"9","author":"Mussbacher","year":"2020","journal-title":"Cells"},{"issue":"11","key":"2023041309385978400_","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1373\/clinchem.2010.147405","article-title":"The MicroRNA spectrum in 12 body fluids","volume":"56","author":"Weber","year":"2010","journal-title":"Clin Chem"},{"key":"2023041309385978400_","doi-asserted-by":"crossref","first-page":"115787","DOI":"10.1016\/j.bone.2020.115787","article-title":"Circulating miRNAs in bone health and disease","volume":"145","author":"Grillari","year":"2021","journal-title":"Bone"},{"key":"2023041309385978400_","doi-asserted-by":"crossref","first-page":"115104","DOI":"10.1016\/j.bone.2019.115104","article-title":"MicroRNA levels in bone and blood change during bisphosphonate and teriparatide therapy in an animal model of postmenopausal osteoporosis","volume":"131","author":"Kocijan","year":"2020","journal-title":"Bone"},{"issue":"6","key":"2023041309385978400_","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/jbmr.4276","article-title":"Longitudinal changes of circulating miRNAs during bisphosphonate and teriparatide treatment in an animal model of postmenopausal osteoporosis","volume":"36","author":"Weigl","year":"2021","journal-title":"J Bone Miner Res"},{"key":"2023041309385978400_","first-page":"4251","author":"Xu","year":"2020"},{"issue":"8","key":"2023041309385978400_","doi-asserted-by":"crossref","first-page":"e2885","DOI":"10.1210\/clinem\/dgaa368","article-title":"Serum profile of microRNAs linked to bone metabolism during sequential treatment for postmenopausal osteoporosis","volume":"105","author":"Yavropoulou","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2023041309385978400_","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1210\/jc.2017-02406","article-title":"Changes of circulating MicroRNAs in response to treatment with teriparatide or denosumab in postmenopausal osteoporosis","volume":"103","author":"Anastasilakis","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2023041309385978400_","author":"Dachverband Osteologie e.V","year":"2017"},{"issue":"11","key":"2023041309385978400_","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1210\/jc.2016-2365","article-title":"Circulating microRNA signatures in patients with idiopathic and postmenopausal osteoporosis and fragility fractures","volume":"101","author":"Kocijan","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2023041309385978400_","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.3390\/ijms23031226","article-title":"A MicroRNA next-generation-sequencing discovery assay (miND) for genome-scale analysis and absolute quantitation of circulating MicroRNA biomarkers","volume":"23","author":"Khamina","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2023041309385978400_","doi-asserted-by":"crossref","first-page":"233","DOI":"10.12688\/f1000research.94159.1","article-title":"miND (miRNA NGS discovery pipeline): a small RNA-seq analysis pipeline and report generator for microRNA biomarker discovery studies [version 1; peer review: 1 approved with reservations]","volume":"11","author":"Diendorfer","year":"2022","journal-title":"F1000Res"},{"issue":"W1","key":"2023041309385978400_","doi-asserted-by":"crossref","first-page":"W244","DOI":"10.1093\/nar\/gkaa467","article-title":"miRNet 2.0: network-based visual analytics for miRNA functional analysis and systems biology","volume":"48","author":"Chang","year":"2020","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2023041309385978400_","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: Kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"2023041309385978400_","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/nbt.3947","article-title":"An integrated expression atlas of miRNAs and their promoters in human and mouse","volume":"35","author":"de Rie","year":"2017","journal-title":"Nat Biotechnol"},{"issue":"W1","key":"2023041309385978400_","doi-asserted-by":"crossref","first-page":"W566","DOI":"10.1093\/nar\/gkv468","article-title":"Clustvis: a web tool for visualizing clustering of multivariate data using principal component analysis and heatmap","volume":"43","author":"Metsalu","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"2023041309385978400_","article-title":"Supplementary data for: circulating miRNAs respond to denosumab treatment after two years in postmenopausal women with osteoporosis\u2014the MiDeTe-study, figshare, dataset","author":"Carro V\u00e1zquez"},{"issue":"12","key":"2023041309385978400_","doi-asserted-by":"crossref","first-page":"6534","DOI":"10.3390\/ijms23126534","article-title":"Effect of anti-osteoporotic treatments on circulating and bone MicroRNA patterns in osteopenic ZDF rats","volume":"23","author":"V\u00e1zquez D","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2023041309385978400_","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1530\/EJE-16-1027","article-title":"Increased osteoclastogenesis in patients with vertebral fractures following discontinuation of denosumab treatment","volume":"176","author":"Anastasilakis","year":"2017","journal-title":"Eur J Endocrinol"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgac667\/47632854\/dgac667.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/5\/1154\/49873780\/dgac667.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/5\/1154\/49873780\/dgac667.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T13:15:59Z","timestamp":1701436559000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/108\/5\/1154\/6835096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,19]]},"references-count":36,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,11,19]]},"published-print":{"date-parts":[[2023,4,13]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgac667","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,5,1]]},"published":{"date-parts":[[2022,11,19]]}}}